San Francisco, CA, United States of America

Derek Hansen


 

Average Co-Inventor Count = 14.1

ph-index = 3

Forward Citations = 109(Granted Patents)


Location History:

  • Half Moon Bay, CA (US) (2009)
  • San Francisco, CA (US) (2012 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Discovering Innovations by Inventor Derek Hansen

Introduction

Derek Hansen, an accomplished inventor based in San Francisco, CA, has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, his innovations aim to address critical health issues, particularly in managing inflammation-related diseases.

Latest Patents

Hansen's latest patents focus on heteroaryl sulfonamides that act as potent antagonists of the CCR2 receptor. These compounds have been shown through animal testing to be effective in treating various inflammation conditions, a hallmark disease associated with CCR2. Generally comprising aryl sulfonamide derivatives, these compounds are instrumental in pharmaceutical compositions and methods for treating CCR2-mediated diseases. They also serve as valuable controls in assays designed to identify further CCR2 antagonists.

Career Highlights

Currently, Derek Hansen is associated with ChemoCentryx, Inc., where he has continued to drive innovation in the development of therapeutic solutions. His expertise and commitment to research have firmly established him as a key figure in the pharmaceutical landscape.

Collaborations

Throughout his career, Hansen has collaborated with other talented professionals, including coworkers Solomon Ungashe and Zheng Wei. These alliances enhance the innovative work being pursued at ChemoCentryx, leading to advancements that benefit the medical field.

Conclusion

Derek Hansen's contributions to the field of pharmaceuticals exemplify the impact of dedicated inventors in addressing complex health challenges. Through his innovative patents and collaborative efforts, he continues to pave the way for new treatment possibilities for diseases linked to inflammation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…